Data from EMA (European Medicines Agency) - Curated by Toby Galbraith - Last updated 09 August 2017

Indication(s)

Neuropathic pain
Pregabalin Pfizer is indicated for the treatment of peripheral and central neuropathic pain in adults.

Epilepsy
Pregabalin Pfizer is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.

Generalised anxiety disorder
Pregabalin Pfizer is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Cushing's Syndrome

Cushing’s syndrome shares symptoms such as hypertension, glucose intolerance and obesity with other common conditions – how can you confidently diagnose this rare disorder?

Visit Cushing's Syndrome

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

Visit Fluid Management

Related Content

More information

Category Value
Agency product number EMEA/H/C/003880
Orphan designation No
Date First Approved 10-04-2014
Type Medicinal product subject to medical prescription
Marketing authorisation holder Pfizer Limited